NFSG Corp Acquires 5,553 Shares of Colgate-Palmolive Company $CL

NFSG Corp increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 831.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,221 shares of the company’s stock after buying an additional 5,553 shares during the period. NFSG Corp’s holdings in Colgate-Palmolive were worth $531,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. V Square Quantitative Management LLC raised its stake in shares of Colgate-Palmolive by 5.2% during the third quarter. V Square Quantitative Management LLC now owns 19,591 shares of the company’s stock valued at $1,672,000 after acquiring an additional 968 shares during the last quarter. Cohen Klingenstein LLC lifted its holdings in shares of Colgate-Palmolive by 9.0% during the third quarter. Cohen Klingenstein LLC now owns 167,669 shares of the company’s stock worth $14,306,000 after purchasing an additional 13,870 shares during the period. Barlow Wealth Partners LLC lifted its holdings in shares of Colgate-Palmolive by 11.9% during the third quarter. Barlow Wealth Partners LLC now owns 7,309 shares of the company’s stock worth $624,000 after purchasing an additional 775 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Colgate-Palmolive by 151.4% in the third quarter. Assenagon Asset Management S.A. now owns 4,276,774 shares of the company’s stock worth $364,894,000 after purchasing an additional 2,575,530 shares during the last quarter. Finally, Brindle & Bay Financial Advisors LLC grew its stake in shares of Colgate-Palmolive by 38.3% in the third quarter. Brindle & Bay Financial Advisors LLC now owns 14,898 shares of the company’s stock worth $1,271,000 after purchasing an additional 4,127 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on CL shares. TD Cowen increased their price objective on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. Jefferies Financial Group reaffirmed a “hold” rating and set a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Barclays upped their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Morgan Stanley reissued an “overweight” rating and issued a $104.00 price target (up from $100.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Finally, Weiss Ratings cut Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Thirteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $97.95.

Colgate-Palmolive Trading Up 1.5%

Shares of NYSE:CL traded up $1.35 during trading on Friday, reaching $94.02. The stock had a trading volume of 5,775,087 shares, compared to its average volume of 5,409,072. The firm’s fifty day moving average is $89.05 and its 200 day moving average is $89.02. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The stock has a market cap of $74.95 billion, a price-to-earnings ratio of 37.31, a P/E/G ratio of 4.43 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same period in the prior year, the company posted $0.92 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is 84.13%.

Insiders Place Their Bets

In other news, CEO Noel R. Wallace sold 161,021 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the transaction, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.